Abstract
Central nervous system (CNS) involvement by Hodgkin Lymphoma (HL) is rarely reported. Retrospective and prospective cohort studies suggest an incidence of 0.2–0.5%, mostly in relapsed disease. In spite of a 3 to 18-fold increased risk of HL in patients with human immunodeficiency virus (HIV), only two cases have been reported so far. In this paper, we now report a third case of HIV patient with HL who progressed with isolated CNS infiltration after a standard chemotherapy induced clinical remission. In 1991, when the first case of intracerebral involvement in HIV+ HL was reported an increase of this type of cases would have been expected, but only one more case has been reported since then.References
- Levine A. Hodgkin’s Disease in the setting of human immunodeficiency virus infection. Monogr Natl Cancer Inst. 1998; 23:37-42. Google Scholar
- Tirelli U. Hodgkin’s disease and human immunodeficiency virus infection: clinicopathologic and virologic features of 114 patients from the Italian Cooperative Groups on AIDS and Tumors. J Clin Oncol. 1995; 13 (7):1758-67. Google Scholar
- Hair LS. Intracerebral Hodgkin’s Disease in a Human Immunodeficiency Virus-Seropositive Patient. Cancer. 1991; 67:2931-4. Google Scholar
- Massaeweh Suleiman. HIV-related Hodgkin’s disease with central nervous system involvement and association with Epstein-Barr Virus. Am J Hematol. 2003; 72:216-219. Google Scholar
- Hirmiz K. Intracraneal presentation of systemic Hodgkin’s disease. Leuk Lymphoma. 2004; 45(8):1667-71. Google Scholar
- Sheehan T. Central nervous system involvement in haematological malignancies. Clin Lab Haematol. 1989; 11 (4):331-8. Google Scholar
- Dujovny M. Intracranial manifestations of Hodgkin’s disease. Surg Neurol. 1980; 13 (4):258-65. Google Scholar
- Sapozink MD. Intracranial Hodgkin’s Disease. A report of 12 cases and review of the literature. Cancer. 1983; 52 (7):1301-7. Google Scholar
- Errante D. Combined antineoplastic and antiretroviral therapy for patients with Hodgkin’s disease and human immunodeficiency virus infection. A prospective study of 17 patients. The italian cooperative group on AIDS and tumors. Cancer. 1994; 73:437-44. Google Scholar
- Levine AM. Chemotherapy consisting of doxorubicin, bleomycin, vinblastine, and dacarbazine with granulocyte-colony-stimulating factor in HIV-infected patients with newly diagnosed Hodgkin’s disease: a prospective, multi-institutional AIDS clinical trials group study (ACTG 149). J Acquir Immune Defic Syndr. 2000; 24 (5):444-50. Google Scholar
- Spina M. Stanford V regimen and concomitant HAART in 59 patients with Hodgkin disease and HIV infection. Blood. 2002; 100(6):1984-1988. Google Scholar
- Hartmann P. BEACOPP therapeutic regimen for patients with Hodgkin’s disease and HIV infection. Annals of Oncology. 2003; 14:1562-9. Google Scholar
- Xicoy B, Ribera JM. Results of treatment with doxorubicin, bleomycin, vinblastine and dacarbazine and highly active antiretroviral therapy in advanced stage, human immunodeficiency virus-related Hodgkin’s lymphoma. Haematologica. 2007; 92 (02):191-8. Google Scholar